Literature DB >> 28848014

Intracavitary and Systemic Daptomycin for Successful Treatment of a Postpneumonectomy Intrathoracic Infection.

Paloma Sangro1, Francisco Carmona-Torre1,2, Miguel Mesa3, Jose L Del Pozo2,4, Jose R Yuste5,2.   

Abstract

Treatment of an infected postpneumonectomy cavity is very difficult. We present a patient with an infection of a postpneumonectomy cavity by Staphylococcus epidermidis treated with local daptomycin for different dwell times, maintaining high antibiotic levels above the MIC. Clinical and microbiological cure were achieved successfully.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Staphylococcus; daptomycin; intracavitary; postpneumonectomy cavity; treatment

Mesh：

Substances：

Year:  2017        PMID： 28848014      PMCID： PMC5655043          DOI： 10.1128/AAC.01330-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  8 in total

1.  Effect of glucose concentration on the stability of daptomycin in peritoneal solutions.

Authors:  Maria Asunción Parra; Miguel Angel Campanero; Belen Sádaba; Angel Irigoyen; Laura García-López; Maria Jose Fernandez-Reyes; Jose Ramon Azanza
Journal:  Perit Dial Int       Date:  2013 Jul-Aug       Impact factor: 1.756

2.  Daptomycin exposure and the probability of elevations in the creatine phosphokinase level: data from a randomized trial of patients with bacteremia and endocarditis.

Authors:  Sujata M Bhavnani; Christopher M Rubino; Paul G Ambrose; George L Drusano
Journal:  Clin Infect Dis       Date:  2010-06-15       Impact factor: 9.079

Review 3.  Daptomycin: a novel cyclic lipopeptide antimicrobial.

Authors:  Christopher A Schriever; Cristina Fernández; Keith A Rodvold; Larry H Danziger
Journal:  Am J Health Syst Pharm       Date:  2005-06-01       Impact factor: 2.637

4.  Successful use of intraperitoneal daptomycin in the treatment of vancomycin-resistant enterococcus peritonitis.

Authors:  Sarah C Huen; Isaac Hall; Jeffrey Topal; Rex L Mahnensmith; Ursula C Brewster; Ali K Abu-Alfa
Journal:  Am J Kidney Dis       Date:  2009-02-23       Impact factor: 8.860

5.  Increased killing of staphylococci and streptococci by daptomycin compared with cefazolin and vancomycin in an in vitro peritoneal dialysate model.

Authors:  Elizabeth D Hermsen; Laurie B Hovde; John R Hotchkiss; John C Rotschafer
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

6.  Causes and management of postpneumonectomy empyemas: our experience.

Authors:  Grzegorz Kacprzak; Marek Marciniak; Emanuel Addae-Boateng; Jerzy Kolodziej; Konrad Pawelczyk
Journal:  Eur J Cardiothorac Surg       Date:  2004-09       Impact factor: 4.191

Review 7.  Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens.

Authors:  Christopher F Carpenter; Henry F Chambers
Journal:  Clin Infect Dis       Date:  2004-03-11       Impact factor: 9.079

8.  Glucose Augments Killing Efficiency of Daptomycin Challenged Staphylococcus aureus Persisters.

Authors:  Marcel Prax; Lukas Mechler; Christopher Weidenmaier; Ralph Bertram
Journal:  PLoS One       Date:  2016-03-09       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.